Status:
COMPLETED
the Use of Tranexamic Acid to Prevent the Bleeding in Bariatric Surgery
Lead Sponsor:
Cairo University
Conditions:
Haemorrhage
Bariatric Surgery Candidate
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Our study aims at evaluating the role of tranexamic acid in bariatric surgery since, The effect of conservative therapy using tranexamic acid for postoperative hemorrhage after bariatric surgery is st...
Detailed Description
Participants were randomized in a 1:1 ratio to receive tranexamic acid or placebo using a computer-generated block randomization sequence (block size = 4) prepared by an independent pharmacist. Alloca...
Eligibility Criteria
Inclusion
- Patients aged 18-60 years were eligible if they had a body mass index (BMI) ≥ 35 kg/m², or ≥ 30 kg/m² with at least one obesity-related diseases(type 2 diabetes, hypertension, or obstructive sleep apnea).
Exclusion
- Patients were excluded if they had a known coagulopathy or platelet disorder, a history of venous thromboembolism, myocardial infarction, or cerebrovascular accident, or if they on anticoagulant or antiplatelet therapy within ten days before surgery. Additional exclusion criteria included prior bariatric or major upper abdominal surgery, allergy or hypersensitivity to tranexamic acid, chronic kidney disease (stage 4-5), significant hepatic impairment, pregnancy or lactation.
- Patient with alzheimer disease
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT07187258
Start Date
July 1 2024
End Date
July 1 2025
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Giza, Manial, Egypt, 1714